Girish Pathangey

🫀Fellow @MayoAZCVFellows 🌵☀️| @DartmouthHealth @OUWB @ASUEngineering | ☕ Coffee in hand, heart in collaboration & patient-centered care

[Girish Pathangey @GPathangey]

Lots of excitement and potential for high-risk PCI. Looking forward to seeing more data and, eventually, whether this tech can be expanded to cardiogenic shock cohort.

[CircInterventions @CircIntv]

A novel low-profile (10F) percutaneous LV support device with up to 5.5 L/min demonstrates favorable performance and device-related safety in an early high-risk PCI feasibility study. The SUPPORT I Study. @azeemlatib @Kandzari https://t.co/Woa9R6ldZL

[Mahmoud Abdelnabi @M_H_Abdelnabi]

Checkout our latest publications “Cannabidiol in Cardiovascular Disease: A Review of Current Evidence and Future Directions”

https://t.co/zlN8ONjz6V

@GPathangey
@ramziw_
@ChadiAyoub1

@MayoClinicCV
@MayoAZCVFellows

[Girish Pathangey @GPathangey]

@DrMCTan @ACCinTouch @MayoAZCVFellows @MayoClinic Congratulations Min!

[Min Choon Tan @DrMCTan]

Honored and excited to join this @ACCinTouch committee as a fellow-in-training and learn from the outstanding group of EP faculty! 🫀

@MayoAZCVFellows @MayoClinic

[Mahmoud Abdelnabi @M_H_Abdelnabi]

Honored to serve as a Member of the Fellows in Training (FIT) Section Leadership Council 🫀 @ACCinTouch

Grateful for the support @MayoClinicCV
@MayoAZCVFellows
#ACCFIT
#AHAFIT
#cardiotwitter

[JCM MDPI @JCM_MDPI]

#mdpijcm
#LatestPaper Sharing
#GraphicalAbstract
Beyond Lipids and Platelets: A Review of Anti-Inflammatory Strategies in Secondary Prevention of #AcuteCoronarySyndromes
👉https://t.co/EvtU1CgCen
👥@GPathangey @M_H_Abdelnabi
🏬@MayoClinic
@MediPharma_MDPI

[Mayo Clinic AZ CV Fellows @MayoAZCVFellows]

We are excited to welcome our incoming fellows. Congratulations! We’re honored to have you and look forward to an incredible journey ahead in sunny AZ ☀️ #ACCFIT #CardioTwitter 🫀

[Girish Pathangey @GPathangey]

Residual inflammation remains a key driver of recurrent events post-#ACS. Our @JCM_MDPI review examines how IL-1β, IL-6, NLRP3 & beyond may redefine secondary prevention.

@Mo_Allam90 @M_H_Abdelnabi @kwanleemd D.Sorajja D.Fortuin M.Bhakta

https://t.co/2uezIwOR0x

[Girish Pathangey @GPathangey]

A joy to return to my @ASUEngineering roots as a guest speaker for the senior capstone course. Grateful to reconnect with the place that started my journey and meet the next generation of innovators. Thank you Dr. Pizziconi! @MayoAZCVFellows #ASUBME #FutureInnovators

[Girish Pathangey @GPathangey]

Honored to present and participate #TCT2025, and even more inspired by the incredible sessions from @MayoClinicCV and @DHHeartVascular colleagues and mentors.

@ChadiAyoub1 @M_H_Abdelnabi DFortuin @mnyoung1

[Mahmoud Abdelnabi @M_H_Abdelnabi]

I was honored to present several abstracts on SGLT2 benefits in TMVR and 3DE benefits in rheumatic TV along with a challenging coronary case in cases with the masters!

Next stop 🔜 #AHA25

#TCT2025 @TCTConference @crfheart @MayoClinicCV @MayoAZCVFellows

[Mayo Clinic CV @MayoClinicCV]

Wrangle CV risk at the #ASE2025 Carotid Rodeo! 🫀From plaque scoring to ultrasound vs. calcium scoring, this interactive session includes @stanhenkin & includes case presentations, audience Q&A, and expert panel insights. @ASE360

[Mahmoud Abdelnabi @M_H_Abdelnabi]

Checkout our latest “VO2 Max in Clinical Cardiology: Clinical Applications, Evidence Gaps, and Future Direction” discussing various clinical applications of VO2.
https://t.co/HkRrggodiM
@MayoClinicCV
@MayoAZCVFellows
@ramziw_
@hoangnhat_pham
@GPathangey
@ChadiAyoub1

[Mayo Clinic AZ CV Fellows @MayoAZCVFellows]

Extremely proud of our fellow representation at #ESCCongress2025 in Madrid! Excellent work!

[Girish Pathangey @GPathangey]

Thrilled to share our @MayoClinicProc first known case of constrictive pericarditis improved with rilonacept (IL-1 inhibition)—a potential new expanded role for targeted anti-inflammatory therapy. #Pericarditis #CardioTwitter @ChadiAyoub1 @MayoAZCVFellows

https://t.co/QtZlq8dtNw

[Mayo Clinic CV @MayoClinicCV]

David Simper, M.D, @EiadHabib @ramziw_ & @CNKanaan from @MayoClinic in AZ stopped by our #ESCCongress Booth A210 this morning. Swing by to learn more about research and educational programs #CardioTwitter @escardio w/ @MayoAZCVFellows

[Fadi Shamoun, MD @FadiShamounMD]

Proud of our team at Mayo Clinic Arizona who are working tirelessly to advance the science and improve patient care in the field of arterial aneurysms and dissection.@BernardBendokMD @thaiscoutinhoCV @stanhenkin @wellsbryanj @RLeLeiko @MayoAZCVFellows

[Christopher Kanaan, MD @CNKanaan]

Check out our latest study on colchicine post AF ablation!
@ramziw_ @hoangnhat_pham @MayoAZCVFellows @JAHA_AHA

https://t.co/cegC1Iz9Os

[Jordan Strom, MD, MSc, FACC, FASE @DocStrom]

Don't miss this special event - join Chadi Ayoub and I @ASE360 as we discuss foundational principles of #AI with @Microsoft AI's Ivan Tarapov (https://t.co/8aFr0VrevA) next Thursday. @SmithBIDMC @ppsengupta1 @alfonsowallermd @BidmcCvi @tabrahammd @iamritu @purviparwani

[Stanislav Henkin @stanhenkin]

Amazing job @NicholeBrunton leading a comprehensive review on #IntermediateRiskPE! A must read for all #PE enthusiasts. @dinubalanescu @MayoClinicCV @mnyoung1 @EricSecemskyMD @SVM_tweets @ACCinTouch